Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Jul;65(1):19–27.

Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

M Mengistu, E Laryea, A Miller, J R Wall
PMCID: PMC1542264  PMID: 3539423

Abstract

The clinical significance of a circulating autoantibody against a recently identified soluble human eye muscle-derived antigen was studied in patients with Graves' ophthalmopathy and autoimmune thyroid disorders. Tests were positive in 73% of patients with Graves' ophthalmopathy, including six of seven with no associated thyroid disease (euthyroid Graves' disease). Tests were also positive in 27% of patients with hyperthyroidism but no clinically apparent eye disease, in 13% of patients with Hashimoto's thyroiditis without eye disease, in two of 12 patients with subacute thyroiditis, in one of 20 patients with nonimmunological thyroid disorders but in none of 39 normal subjects. There were significant positive correlations between serum levels of the antibody (expressed as a titre) and the severity of the eye muscle component quantified as an index as well as the duration of the eye disease. Antibodies were detected in three of five patients with only lid lag and state who subsequently developed active ophthalmopathy, in six of nine patients who developed eye disease after treatment of their hyperthyroidism and in one of eight first degree relatives of patients with Graves' ophthalmopathy. In addition three of the 12 patients with autoimmune thyroid disease without apparent eye involvement, but positive antibody tests, have developed ophthalmopathy since the time of testing. These findings suggest that tests for antibodies against a soluble human eye muscle antigen may be useful clinically as a diagnostic test and to predict the onset of eye disease in predisposed patients and subjects.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bogner U., Schleusener H., Wall J. R. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab. 1984 Oct;59(4):734–738. doi: 10.1210/jcem-59-4-734. [DOI] [PubMed] [Google Scholar]
  2. Faryna M., Nauman J., Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy. Br Med J (Clin Res Ed) 1985 Jan 19;290(6463):191–192. doi: 10.1136/bmj.290.6463.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gamblin G. T., Harper D. G., Galentine P., Buck D. R., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med. 1983 Feb 24;308(8):420–424. doi: 10.1056/NEJM198302243080803. [DOI] [PubMed] [Google Scholar]
  4. Gorman C. Ophthalmopathy of Graves' disease. N Engl J Med. 1983 Feb 24;308(8):453–454. doi: 10.1056/NEJM198302243080811. [DOI] [PubMed] [Google Scholar]
  5. Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) 1984 Apr 21;288(6425):1183–1186. doi: 10.1136/bmj.288.6425.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J. R. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet. 1982 Dec 18;2(8312):1353–1356. doi: 10.1016/s0140-6736(82)91267-3. [DOI] [PubMed] [Google Scholar]
  7. Kriss J. P., Pleshakov V., Rosenblum A. L., Holderness M., Sharp G., Utiger R. Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab. 1967 Apr;27(4):582–593. doi: 10.1210/jcem-27-4-582. [DOI] [PubMed] [Google Scholar]
  8. Kuroki T., Kodama K., Carayon P., Ruf J., Miller A., Wall J. R. Use of mouse and human monoclonal antibodies to investigate the immunologic basis of Graves' ophthalmopathy. Mt Sinai J Med. 1986 Jan;53(1):60–69. [PubMed] [Google Scholar]
  9. Kuroki T., Ruf J., Whelan L., Miller A., Wall J. R. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol. 1985 Nov;62(2):361–370. [PMC free article] [PubMed] [Google Scholar]
  10. RUNDLE F. F., FINLAY-JONES L. R., NOAD K. B. Malignant exophthalmos: a quantitative analysis of the orbital tissues. Australas Ann Med. 1953 Nov;2(2):128–135. doi: 10.1111/imj.1953.2.2.128. [DOI] [PubMed] [Google Scholar]
  11. Sisson J. C., Kothary P., Kirchick H. The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. J Clin Endocrinol Metab. 1973 Jul;37(1):17–24. doi: 10.1210/jcem-37-1-17. [DOI] [PubMed] [Google Scholar]
  12. Smith B. R., Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974 Aug 24;2(7878):427–431. doi: 10.1016/s0140-6736(74)91815-7. [DOI] [PubMed] [Google Scholar]
  13. Strakosch C. R., Joyner D., Wall J. R. Thyroid stimulating antibodies in patients with subacute thyroiditis. J Clin Endocrinol Metab. 1978 Feb;46(2):345–348. doi: 10.1210/jcem-46-2-345. [DOI] [PubMed] [Google Scholar]
  14. Volpé R. The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease. Ann Intern Med. 1977 Jul;87(1):86–99. doi: 10.7326/0003-4819-87-1-86. [DOI] [PubMed] [Google Scholar]
  15. Wall J. R., Trewin A., Fang S. L., Ingbar S. H., Braverman L. E. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest. 1978 Jul;1(3):253–258. doi: 10.1007/BF03350389. [DOI] [PubMed] [Google Scholar]
  16. Wall J. R., Walters B. A., Grant C. Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest. 1979 Oct-Dec;2(4):375–378. doi: 10.1007/BF03349336. [DOI] [PubMed] [Google Scholar]
  17. Wall J. R., Wright D. J. Antibodies against testicular germinal cells in lepromatous leprosy. Clin Exp Immunol. 1974 May;17(1):51–59. [PMC free article] [PubMed] [Google Scholar]
  18. Werner S. C. Classification of the eye changes of Grave's disease. J Clin Endocrinol Metab. 1969 Jul;29(7):982–984. doi: 10.1210/jcem-29-7-982. [DOI] [PubMed] [Google Scholar]
  19. Werner S. C. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977 Jan;44(1):203–204. doi: 10.1210/jcem-44-1-203. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES